of large-scale protein quantification, which represents net changes in protein synthesis and breakdown. However, measuring the rate of protein synthesis is the only way to determine the translational rate of gene transcripts. Here, we report a technique to measure the rate of incorporation of amino acids from ingested protein labeled with stable isotope into individual plasma proteins. This approach involves three steps: 1) production of stable isotope-labeled milk whey protein, oral administration of this intrinsically labeled protein, and subsequent collection of blood samples; 2) fractionation of the plasma and separation of the individual plasma proteins by a combination of anion exchange high-pressure liquid chromatography and gel electrophoresis; and 3) identification of individual plasma proteins by tandem mass spectrometry and measurement of stable isotopic enrichment of these proteins by gas chromatography-mass spectrometry. This method allowed the measurement of the fractional synthesis rate (FSR) of 29 different plasma proteins by using the same precursor pool. We noted a 30-fold difference in FSR of different plasma proteins with a wide range of physiological functions. This approach offers a tremendous opportunity to study the regulation of plasma proteins in humans in many physiological and pathological states.
PLASMA PROTEINS play crucial physiological roles, and the alterations of certain plasma proteins indicate specific pathological states. Some of these changes are biomarkers of clinical disorders such as coronary artery disease (2) and cancer (25) . However, only a limited number of plasma proteins have been measured and identified as markers of common clinical conditions, and the regulation of their plasma levels remains to be clearly defined. Recent technology based on in vitro stable isotope labeling methods (18) permits relative quantification of multiple plasma proteins. However, such techniques for measuring the relative concentrations of individual plasma proteins and peptide patterns in plasma do not allow us to understand the regulation at the molecular levels of plasma protein production and the maintenance of their levels. Gene array technology allows simultaneous measurement of the transcript levels of all known genes if appropriate tissue samples are available (26) . This approach allows quantification of the transcript level changes of multiple genes and various functional clusters in response to physiological interventions and pathological states. There are, however, substantial discrepancies between changes in transcript levels and protein expression levels (9, (15) (16) (17) 19) . The potential explanation for these discrepancies is the rapid turnover (synthesis and degradation) of proteins that may occur in many conditions so that concentrations of proteins may not reflect the actual synthesis rate, representing the translational rates of gene transcripts (28) . It is therefore important not only to know the transcript and protein expression levels but also the rate at which the proteins are synthesized.
The measured abundance of a protein is the net result of its synthesis and breakdown. If these two processes are in equilibrium (despite upward or downward changes), the net concentration of the protein remains unchanged. During acute intervention, such as during a meal, although there is an increase in the rate of synthesis of specific proteins, such as albumin (11) , there are no measurable changes in concentrations of many proteins because of their relatively slow turnover. Furthermore, protein quantification techniques are not sufficiently sensitive to detect changes that occur in very low abundance proteins, which may have a fast turnover rate. All of these limitations of in vitro labeling methods have led to the development of in vivo labeling of proteins for protein quantification, which has thus far only been applied to single-cell organisms (10, 29) , cells in culture (10, 30) , and to a limited extent in multicellular organisms such as Caenorhabditis elegans and Drosophila melanogaster (24) . Proteomic strategies have also been developed for the relative measurement of protein turnover in chickens (12) and in cultures of single-cell organisms such as yeast (35) and bacteria (8) . However, the aforementioned approaches require a high enrichment of proteins, which can be achieved by feeding animals for long periods with highly enriched isotopes or in single-cell organisms that have rapid turnover. Moreover, none of the above approaches provide a direct measurement of the synthesis rate of proteins, nor are they practical in human studies. Also, the aforementioned methods, as well the methods for protein quantification, do not have the sufficient precision for human studies, since these methodologies are highly dependent on the application of equal amounts of sample to be compared by mass spectrometry (MS) analysis. We have therefore developed an approach to simultaneously measure fractional synthesis rates of multiple plasma proteins and have demonstrated the method after a meal that contained intrinsically labeled proteins.
EXPERIMENTAL PROCEDURES
Subjects. Six healthy adults (2 men and 4 women, average age 21.8 Ϯ 0.7 yr) were enrolled in the study. Average body mass index was 22.8 Ϯ 1.1 kg/m 2 . Body composition was measured by dualenergy X-ray absorptiometry (23 Ϫ1 ⅐ h Ϫ1 using a peristaltic pump for 36 h. The cow was milked every 6 h for 36 h during the infusion and for another 24 h after discontinuation of the infusion. The milk collected during the period of isotope infusion and 24 h after the infusion was pooled. The whey protein was separated using a standardized ultrafiltration technique as previously described (5). The whey protein was then freeze-dried and stored for the experiments. The Phe concentration in whey protein was estimated as 4%, as was previously reported (37) . Isotopic enrichment of [ 13 C6]Phe whey milk protein was determined by gas chromatography-quadrupole mass spectrometry (GC-QMS). The whey protein was hydrolyzed overnight, at 110°C, using 6 M hydrochloric acid as previously described (3) . The technique used for processing of amino acids and GC-QMS analysis was the same for plasma free Phe and the amino acid derived from hydrolyzed whey protein. The isotopic enrichment of whey protein was estimated to be 17.8 molar percent excess (MPE).
Experimental design. The study protocol was reviewed and approved by the Mayo Foundation Institutional Review Board, and informed consent was obtained from each participant prior to the study. FFM was used for estimating meal energy and protein content. For 3 days before the study, all subjects received a weight-maintaining diet consisting of 20% protein, 50% carbohydrate, and 30% fat, which was provided by the General Clinical Research Center (GCRC) at Mayo Clinic. All subjects received a standard meal by 8 PM on the day before the study and then fasted until the morning in the GCRC. Ingestion of water was allowed. The femoral artery, femoral vein, and hepatic vein were catheterized by a vascular radiologist. Samples from the femoral vein were used for a separate set of analyses. Catheter sheaths were placed in the right femoral artery and femoral vein through the arterial sheath. Hepatic vein catheters were inserted under fluoroscopic control, and the approximate position was confirmed by use of an injectable, nonionic contrast medium. A slow infusion of normal saline maintained the patency of the catheters. The femoral artery and hepatic lines were used for collecting blood samples. After baseline blood samples were collected, subjects ingested 0.626 g/kg FFM of whey protein intrinsically labeled with [ring-
13 C6]Phe in combination with a similar amount of casein and 1.8 g/kg FFM of lactose. This provided a total of 1.25 g protein/kg FFM. Blood samples from the femoral artery and hepatic vein were collected at baseline and then every 20 min for 420 min. Baseline and 400-min samples from the femoral artery were used to calculate enrichment for individual plasma proteins. The study was originally designed as a part of a larger physiological experiment, and the additional results will be reported separately.
Separation of individual plasma protein. Femoral arterial plasma samples from baseline and at 400 min of all subjects were used for the analysis of isotopic enrichment of individual plasma proteins. Each plasma sample was subjected to immunoglobulin removal (Affigel Protein-A; Bio-Rad, Hercules, CA) followed by albumin removal (SwellGel Blue; Pierce, Rockford, IL) to reduce the content of these highly abundant proteins. The recovery of proteins following depletion of plasma samples was ϳ20%, based on the estimated total protein concentration in plasma before and after depletion.
Each depleted plasma sample was fractionated further by use of anion exchange HPLC. Samples were loaded onto a PolyWAX LP (PolyLC Columbia USA, Columbia, MD) anion exchange column (9.4 mm ϫ 10 cm) and eluted using a Waters 600E HPLC system. The column was washed for 5 min with buffer A (20 mM Tris, pH 7.5) followed by a gradient of 0 to 100% buffer B (0.8 M sodium acetate in buffer A) over 120 min. The flow rate was 2 ml/min, and the optical density (OD) was monitored at 280 nm. Fifty fractions of 5 ml each were collected. Each fraction was precipitated separately using 10% trichloroacetic acid. The precipitate from each fraction was dissolved in SDS sample buffer, and SDS-PAGE was performed on an 8 -15% acrylamide gel of 1.5 mm thickness. Each time point had 50 HPLC fractions, and a total of 600 fractions from six subjects were obtained and were subjected to gel electrophoresis (50 fractions were electrophoresed at one time with 25 fractions each on a single gel). The gels were later stained with Coomassie blue. Pairs of 37 gel bands, which were the best resolved and intense from both time points, obtained from 50 fractions of each time point were excised and analyzed for protein identification by tandem mass spectrometry (LC-MS-MS) and for isotopic enrichment by GC-QMS. Figure 1 displays only the lines (HPLC fractions) showing the gel bands that were used for the study. The rest of the HPLC fractions either did not produce any protein gel bands or showed gel bands that were not considered optimal for analysis because of the difficulty in reaching correct protein identification. Although we analyzed a total of 37 gel bands from each sample (50 HPLC fractions), only 29 were identified as single protein and therefore used for isotopic measurement. Plasma proteins were first fractionated into 50 HPLC fractions, and proteins from each fraction were precipitated and subjected to SDS-PAGE on 8 -15% gradient gels using the Bio-Rad Protean-II system. Gels were stained with Coomassie blue to visualize protein gel bands. The figure displays only the lines (HPLC fractions) showing the gel bands that were used for protein identification and isotopic enrichment analysis. The gel bands are numbered to match the protein serial numbers in Tables 2 and 3 . 
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Protein identification by LC-MS-MS.
Gel bands were subjected to in-gel reduction and alkylation, followed by trypsin digestion, as previously described (21, 36) . Peptides were extracted three times, first by adding 2% trifluoroacetic acid (TFA) in water to the digest mixture and then by an equal volume of 60% acetonitrile-0.1% TFA-40% water followed by a final extraction with 100% acetonitrile. Extracts were dried by evaporation (Savant Speedvac) to remove the organic solvent. Samples were dissolved in 0.1% formic acid-2% acetonitrile solution just before injection into the mass spectrometer.
MS analyses were done on a linear ion-trap quadrupole mass spectrometer (LTQ; Thermo Electron, Franklin, MA). The digested peptides were introduced into the LTQ through an automated nanoscale liquid chromatography system (LC Packings, Sunnyvale, CA). The chromatographic separation was performed on a 100-m inside diameter ϫ 15-cm C 18 column (Zorbax; Agilent Technologies, Palo Alto, CA) with a linear gradient elution from 100% buffer A (0.1% formic acid-acetonitrile, 98:2, vol/vol) to 60% buffer B (0.1% formic acid-acetonitrile, 2:98, vol/vol) in 60 min. The collected data were compared against a nonredundant human database by use of TurboSequest software (University of Washington). Peptide mass tolerance and fragment mass tolerance were set at 1.4 and 0.5 Da, respectively. Identification of individual proteins was confirmed by triplicate analysis of gels bands of baseline samples from three different study subjects.
The tissue origin of each identified proteins as well as their functions were obtained from Human Protein Reference Database (33) and Swiss-Protein database.
Isotopic enrichment of individual plasma proteins derived from gel bands. Isotopic enrichment of Phe derived from hydrolysis of plasma proteins by GC-QMS was measured as described previously (7, 32) . For GC-QMS analysis, gel pieces were washed several times with deionized water and hydrolyzed overnight at 110°C in 6 M hydrochloric acid. Amino acids from the hydrolyzed gel pieces were purified over an AG-50W cation exchange column, eluted with 4 M ammonium hydroxide, and dried by evaporation. Methyl esters were made before acylation with heptafluorobutyric anhydride. Derivatives were dried and resuspended in ethyl acetate for GC-QMS analysis on a Triple Stage Quadrupole (Finnigan TSQ 7000; Thermo Electron) under positive chemical ionization with ammonia gas. Amino acid (Phe ester) separation was carried out on a DB5-ms 30 m ϫ 0.25 mm ϫ 0.25 m capillary column (Agilent Technologies) in the GC oven with helium flow rate of 3 ml/min and the temperature ramp as follows: 100 -152°C at 5°/min, 152-154°C at 1°/min, and 154 -300°C at 20°/min. Selected ion monitoring was performed in profile mode at m/z 396 (M ϩ 3) and m/z 399 (M ϩ 6) for [ 12 C]Phe and [ 13 C6]Phe, respectively (7, 32) . Enrichment (molar percent excess, MPE) was calculated using an equation obtained from a six-point calibration curve. The regression analysis of theoretical and measured enrichment gave regression coefficient (r 2 ) of 0.9998. Replicate measurements of isotopic enrichment of proteins collected from five separate gel bands after gel electrophoresis (as described above) were performed to determine reproducibility (Table 1) . Ten replicate measurements in each of five different protein bands showed a coefficient of variation ranging from 3.4 to 6.5%.
Isotopic enrichment of free Phe in plasma. Isotopic enrichment of free [ 13 C6]Phe in plasma was determined by GC-QMS. We analyzed 23 samples (at Ϫ20 min and every 20 min until 420 min, i.e., 23 samples from each subject and total 276 samples). Each plasma sample (0.1 ml) was acidified using 0.1 ml of 50% acetic acid, and this mixture was passed through an AG-50W cation exchange column. After the column was washed with water, the amino acids were eluted with 4 M ammonium hydroxide followed by evaporation to dryness using a centrifugal evaporator. The tert-butyldimethylsiloxy derivative was prepared and, after removal of excess solvent, resuspended in n-decane for analysis by GC-MS (5973N GC/MS; Agilent Technologies) under electron ionization conditions. Chromatographic separation was carried out on a 30 m ϫ 0.25 mm ϫ 0.25 m DB5-ms capillary column (Agilent Technologies) using helium as carrier gas at 2 ml/min. A ramped temperature program was used: 120 -175°C at 20°/min, 175-195°C at 10°/min, and 195-300°C at 30°/min. A limited scan of the [M Ϫ 57]
ϩ region was performed, m/z 336 -344 with 10 ms dwell for each ion and triplicate injections of each label for each plasma sample compared with similar profiles collected for natural abundance Phe. The MPE of [
13 C6]Phe was calculated above background, as previously described (20) .
Calculation of FSR of plasma proteins. We subtracted the baseline natural isotopic abundance of [
13 C6]Phe in plasma proteins from those samples collected 400 min after the meal (Ie). The integrated values for plasma [ 13 C6]Phe isotopic enrichment of all time points after the administration of the labeled meal were used as the precursor enrichment (P e). The calculation of protein FSR has been described previously (27) . The equation used is as follows: FSR (%/h) ϭ [Ie/ (Pe ⅐ t)] ⅐ 100, in which t represents time (6.67 h).
We used isotopic enrichment (integrated values for 6.67 h) of hepatic venous plasma (P e) as precursor for FSR calculation of proteins derived from liver and femoral arterial plasma enrichment (Pe) to calculate FSR of proteins from tissues other than liver.
Statistical analysis. All values are expressed as means Ϯ SE. Comparison of plasma Phe isotopic enrichment values between hepatic vein and femoral artery was analyzed using a paired t-test.
RESULTS
Isotopic enrichment of plasma Phe and Phe concentration.
As expected, immediately following the ingestion of the meal, both arterial and hepatic venous isotopic Phe enrichment values and Phe concentration increased, and enrichment value remained above natural abundance until the end of the study (Fig. 2) . In contrast, plasma Phe concentration returned near baseline by 360 min. Although both arterial and venous Phe concentrations were similar, the enrichment values were higher in the hepatic vein from 20 to 280 min (4.44 Ϯ 0.24 average MPE for hepatic vein vs. 3.57 Ϯ 0.17 for femoral artery, P Ͻ 0.001).
Isotopic enrichment of individual plasma proteins and precursors. The integrated values of femoral arterial [ 13 C 6 ]Phe enrichment were significantly lower (2.92 Ϯ 0.28) than those of hepatic venous enrichment (3.57 Ϯ 0.33, P Ͻ 0.001). The isotopic enrichment of each of the 29 proteins (Table 2) showed a wide range in enrichment values (0.03 to 0.66 MPE).
Identified proteins and their functions. The proteins identified with corresponding sequest score, percent coverage, and numbers of peptides are shown in Table 2 . The functions, as well as the origins, of the proteins whose synthesis rates are measured are given in Table 3 . The majority of the proteins *Values are means Ϯ SE; n ϭ 10 replicates. MPE, mole percent excess. One representative plasma sample at 400 min after meal ingestion was run 50 g each in 10 wells on an 8 -15% SDS-PAGE. Five separate gel bands (1-5) were excised from each of the 10 lanes of the gel, processed, and performed isotopic enrichment analysis on by GC-MS as described in EXPERIMENTAL PROCEDURES. identified are of liver origin, and others are derived from either B lymphocytes or the intestine.
FSR of plasma proteins. FSR (%/h) of 29 plasma proteins are given in Fig. 3 (1.13 Ϯ 0.16 to 30.91 Ϯ 6.75%/h), demonstrating an ϳ30-fold difference.
DISCUSSION
We measured in vivo FSRs of 29 plasma proteins in healthy people from the rate of incorporation of labeled Phe derived from intrinsically labeled milk protein administered orally. With this technique we were able to observe a 30-fold range in the synthesis rate of plasma proteins. The measurement of FSRs of proteins represents the best measurement of translational rates of gene transcripts, thus offering a potential opportunity to understand the in vivo regulation of specific genes. Unlike previous approaches, limited to the measurement of synthesis rates of only a few plasma proteins (13, 22) , here we utilized a large-scale protein purification approach in combination with mass spectrometry to identify the purified proteins as well as to measure the stable isotopic abundance of Phe in these proteins. We measured postprandial synthesis rates of these proteins not only because the postprandial period is longer than the fasted state but also because the period represents the net anabolic phase.
The use of intrinsically labeled milk whey protein has some advantages in measuring postprandial FSR of plasma proteins. Both tracer amino acid and amino acids derived from the ingested protein appear simultaneously when ingested protein is labeled with the tracer. In contrast, free amino acid tracer Plasma proteins were identified by tandem mass spectrometry. Identification was confirmed by triplicate analysis of baseline samples from 3 different individuals. Sequest score, accession no., no. of peptides, and %coverage are from a representative analysis. Isotopic enrichment values (MPE Ϯ SE) are from all 6 study subjects analyzed by GC-MS. mixed with orally ingested protein appears and disappears faster than amino acids derived from ingested protein because of the time needed to digest the ingested protein by pancreatic enzymes (6) . As a result, the use of free amino acid tracer in blood is a better representation of the actual precursor of protein synthesis in liver when the ingested protein is labeled with amino acid tracer. Another approach is using an intravenous free amino acid tracer to measure postprandial plasma protein synthesis. The problem with this approach is that a meal can dramatically dilute the intravenously administered tracer to low levels due to an increase in unlabeled amino acids appearing from meal proteins (14) . The dilution of the tracer enrichment occurring in the hepatic circulation by the mealderived amino acids transiting through the portal circulation cannot be fully assessed when the tracer is infused systemically. We circumvented this problem by having subjects ingest the tracer-bound protein [ring- 13 C 6 ]Phe-whey as a meal.
Innovative Methodology
E193 SYNTHESIS RATES OF PLASMA PROTEINS
AJP-Endocrinol Metab
We used the hepatic vein free Phe label as precursor for calculating FSR of liver-derived proteins, whereas for other proteins we used arterial label as the precursor. Although the Phe enrichment in hepatic vein and femoral artery was not in a steady state following meal ingestion, the average value is likely to represent the true precursor enrichment values. We used the same precursor values for FSR calculations of all plasma proteins, and therefore the fold differences that we reported are valid. We also determined the differences in isotopic enrichment between arterial and hepatic vein [ 13 C 6 ]Phe and found an average 18% lower enrichment in arterial plasma. This can result in some underestimation of FSR of liver-derived plasma proteins when arterial plasma Phe label is used as precursor. The lower isotopic enrichment of arterial Phe can be explained by unlabeled Phe appearing from degradation of proteins from the peripheral tissues. Theoretically, the hepatic vein that drains blood from liver is likely to represent hepatic [ 13 C 6 ]Phe enrichment in the intracellular compartment of the liver. This assumption is supported by results from previous studies (1, 4) demonstrating that liver tissue fluid and tRNA leucine enrichment are best represented by arterial ketoisocaproate enrichment, which is not different from the hepatic venous leucine enrichment. We appreciate that it is not practical to measure hepatic venous plasma isotopic enrichment for most human studies. The current results demonstrated that the difference in enrichment of hepatic and peripheral Phe enrichment is small. It remains to be determined whether a similar relationship exists for other amino acid tracers as well.
In the present study, we chose anion exchange HPLC as the first dimension separation based on charge and SDS-PAGE as the second dimension to separate plasma proteins instead of a two-dimensional gel electrophoresis to obtain sufficient protein concentration in a single gel band for detection with GC-QMS. The individual plasma proteins were identified by MS-MS as described in EXPERIMENTAL PROCEDURES. In the present study, we selected only 29 gel bands, which were intense and resolved clearly, for analysis. With those bands, we could analyze ϳ10% of the known plasma proteins, which could be separated and identified using gel separation techniques (34) . Our separation approach yielded individual proteins for the analysis. The combination of two one-step procedures used in the present study is not sufficient to isolate the maximal number of plasma proteins. The main difficulty to overcome is the complexity and tremendous variation in individual plasma protein abundance; e.g., albumin is 10 9 -fold more abundant in plasma than troponin T. A combination of different ranges of liquid chromatography columns along with electrophoresis methods can separate and isolate medium-and low-abundance plasma proteins. However, the present report is the first, to our knowledge, to report in vivo synthesis rates of a large number of plasma proteins in humans. Ten replicate experiments from five separate gel bands demonstrated the high precision of the measurement, which offers the opportunity to detect small changes in plasma protein enrichment (Table 1) .
We determined the function and origin of these plasma proteins (Table 3 ) from the Human Protein Reference Database (http://www.hprd.org/query) and Swiss-Protein database (http://www.expasy.ch/cgi-bin/sprot-search-ful). We found that proteins with immunologic functions, such as immunoglobulin heavy-chain constant, and immunoglobulin -chain have more than 10-fold lower synthesis rates than some of the binding proteins, such as retinol-binding proteins and vitamin D-binding proteins. These binding proteins are critical in transporting nutrient molecules, such as vitamin D and retinol, or hormones, such as thyroxine. The production of these proteins is critical to preventing sudden increases in the concentration of free molecules with major functional consequences. In general, it appears that most of the proteins that we identified with a fast FSR are proteins, such as apolipoproteins, that are necessary for transferring lipids or fatty acids to different locations, or acute phase reaction proteins, such as haptoglobin.
The current approach offers the opportunity to determine the effect of various physiological factors, such as growth, aging, hormones, and substrates, as well as pathological states on the rate of synthesis of various circulating proteins. Because these changes are measures of the translational rates of transcripts to proteins, they can be used to obtain precise mechanistic information of the effect of physiological interventions and pathological states. It is conceivable that lack of changes in concentrations of proteins between two study conditions may occur if synthesis and degradation rates change in the same direction at the same magnitude. For example, the synthesis and degradation rates of a single protein or cluster of proteins with similar functions could increase 10-fold in a specific condition with a major effect on functions but no measurable changes in the protein concentrations.
In conclusion, the approach described in the present study enables the measurement of synthesis rates of multiple plasma proteins. Our study uses the labeling of ingested protein to measure the rate at which labeled amino acid is incorporated into multiple plasma proteins, thus enabling us to measure their synthesis rates following a meal. Similar techniques could be used to measure synthesis rates of multiple proteins in the postabsorptive state with intravenous administration of tracers, as has been reported by many authors for the measurement of one or two plasma proteins (31) . In summary, we measured the postprandial synthesis rates of 29 plasma proteins by in vivo labeling of these proteins, thus demonstrating a 30-fold difference in their synthesis rates. Simultaneous measurement of transcript levels and FSR in the same tissue during interventions will allow one to determine whether the intervention affected translation or transcription.
